Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

YE6144

😃Good
Catalog No. T62678Cas No. 3065657-02-2
Alias YE 6144

YE6144 is a prototype IRF5 inhibitor that selectively blocks IRF5 phosphorylation.YE6144 can also inhibit the production of type 1 IFNs (IC50 = 0.09μM).

YE6144

YE6144

😃Good
Catalog No. T62678Alias YE 6144Cas No. 3065657-02-2
YE6144 is a prototype IRF5 inhibitor that selectively blocks IRF5 phosphorylation.YE6144 can also inhibit the production of type 1 IFNs (IC50 = 0.09μM).
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$428-In Stock
5 mg$1,280-In Stock
10 mg$2,150-In Stock
25 mg$3,900-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Appearance:Solid
Color:Orange
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
YE6144 is a prototype IRF5 inhibitor that selectively blocks IRF5 phosphorylation.YE6144 can also inhibit the production of type 1 IFNs (IC50 = 0.09μM).
In vitro
Methods: Human HC PBMC and mouse WT splenocytes were treated with YE6144 (1 μM and 3 μM, 30 minutes), and protein expression was detected by Western blotting. Results: YE6144 inhibited the phosphorylation of IRF5 in the above cells. [1]
In vivo
Methods: YE6144 (40 mg/kg, subcutaneous injection, single dose) was used to treat NZB/W F1 mice with systemic lupus erythematosus (SLE) and its effects were observed. Results: YE6144 was able to inhibit the progression of autoantibody production in mice. Post-onset treatment also inhibited splenomegaly and renal insufficiency. [1]
SynonymsYE 6144
Chemical Properties
Molecular Weight447.94
FormulaC21H27ClFN7O
Cas No.3065657-02-2
SmilesC(=C/C1=CC=C(N=N1)N2CCOCC2)\C=3C=4C(=CC(F)=C(NC[C@H](CC)N)C4)NN3.Cl
Storage & Solubility Information
Storagestore at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 55 mg/mL (122.78 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 10 mg/mL (22.32 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.2324 mL11.1622 mL22.3244 mL111.6221 mL
5 mM0.4465 mL2.2324 mL4.4649 mL22.3244 mL
10 mM0.2232 mL1.1162 mL2.2324 mL11.1622 mL
20 mM0.1116 mL0.5581 mL1.1162 mL5.5811 mL
50 mM0.0446 mL0.2232 mL0.4465 mL2.2324 mL
100 mM0.0223 mL0.1116 mL0.2232 mL1.1162 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy YE6144 | purchase YE6144 | YE6144 cost | order YE6144 | YE6144 chemical structure | YE6144 in vivo | YE6144 in vitro | YE6144 formula | YE6144 molecular weight